NCT00030225已完成2 期
Phase 2 Evaluation of the Vitagen Extracorporeal Liver Assist Device (ELAD) System in the Management of the Patients With Fulminant Hepatic Failure
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 19
- 试验地点
- 14
- 主要终点
- Number of subjects reaching 30-Day survival
研究概览
简要总结
The purpose of this study is to determine if treatment with the ELAD Bioartificial Liver Assist Device is beneficial to patients in Acute Liver Failure either as a bridge to liver transplant or bridge to native liver recovery.
详细描述
Current treatment with modalities in Acute Liver Failure still carry unacceptable morbidity and mortality. It is hoped that by intervening with ELAD a patient will have an opportunity to be bridged to transplant or to avoid transplantation and to have their native liver recover.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 50 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- •Listed for organ transplant at stud entry
- •History of jaundice for greater than 28 days at screening
- •Liver dysfunction due to trauma
- •Concomitant serious disease
结局指标
主要结局
Number of subjects reaching 30-Day survival
时间窗: Study Day 30
30-day survival
次要结局
- 30-day transplant-free survival(Study Day 30)
研究者
研究点 (14)
Loading locations...
相似试验
No Longer Available
不适用
Use of the ELAD® in Patients With Liver Failure to Provide Expanded Access With Cost RecoveryLiver FailureNCT00832273Vital Therapies, Inc.
已完成
2 期
Efficacy and Safety of the Extracorporeal Liver Assist Device (ELAD) in Acute on Chronic HepatitisAcute On Chronic HepatitisNCT00973817Vital Therapies, Inc.62
已完成
1 期
Safety & Efficacy of the Extracorporeal Liver Assist Device (ELAD) System in Patients With Hepatic InsufficiencyAcute HepatitisChronic HepatitisNCT00771446Vital Therapies, Inc.18
Unknown
不适用
Plasma Exchange and Continuous Hemodiafiltration in Treatment of Wilson's Disease-related Liver FailureWilson DiseaseLiver FailureNCT03589820Third Affiliated Hospital, Sun Yat-Sen University60
终止
不适用
Phase 2 Study of Ex-vivo Perfusion and Ventilation of Lungs to Assess Transplant SuitabilityChronic Obstructive Pulmonary Disease (COPD)Cystic FibrosisAlpha-1 Antitrypsin DeficiencyPulmonary HypertensionPulmonary FibrosisSarcoidosisEmphysemaBronchiectasisNCT01241942University of North Carolina, Chapel Hill11